Review
Accepted on 21 Oct 2025
Effectiveness and Safety of Rituximab Monotherapy Versus Conventional Regimens for Adult Idiopathic Membranous Nephropathy: A Real-World Retrospective Study
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders